Results of the American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Practice Survey – Understanding Today to Meet the Needs of Tomorrow

Saunders, Ila M.; Bryk, Amy Wiglesworth; Mayor, JoAl; Tombleson, Rebecca; Betcher, Jeffrey; Eddy, Beth; Melaragno, Adam; Rhodes, Jill; Khan, Tapan K.; Koontz, Susannah E.

doi:10.1016/j.bbmt.2014.11.596

Cited by 1 publication

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3 In early 2014, the ASBMT Pharmacy SIG distributed a survey to approximately 250 HCT pharmacists primarily based in the United States. 8 The purpose of this survey was to collect baseline data regarding the makeup of Pharmacy SIG members, and to obtain a better understanding of pharmacy practice patterns. Pharmacists were queried on a number of different topics, including the use of CPAs at their transplant center.…”

Section: Introductionmentioning

confidence: 99%

“…Primary barriers to implementing CPAs included a lack of support from the transplant center and/or pharmacy administration, CPAs not being legal in state they practiced, and difficulty obtaining insurance reimbursement for services offered under a CPA. 8 While this survey provides a snapshot of the use of pharmacy-driven CPAs in the HCT setting, there are several limitations to these results. First, this survey was not primarily focused on gathering data on CPAs; as a result, specific details of these agreements are lacking.…”

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Characterization of collaborative practice agreements held by hematopoietic stem cell transplant pharmacists

Bryk

Koontz²,

Mayor

et al. 2017

J Oncol Pharm Pract

Self Cite

View full text Add to dashboard Cite

Background Current workforce shortages within the hematopoietic stem cell transplant field necessitate capitalizing on the role of oncology-trained pharmacists. Working within an agreed-upon protocol, pharmacists are able to expand patient care delivery through optimal medication therapy management. Methods An electronic survey was developed by the Advocacy & Policy Working Committee of the American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group and distributed to pharmacists involved in the care of hematopoietic stem cell transplant patients. The primary objective was to assess the current state of collaborative practice agreements in the hematopoietic stem cell transplant setting. Results Forty-eight responses representing 41 institutions were returned. Respondents were mostly female (67%) and practiced in the adult setting (83%). Reponses represented a range of practice experience in hematopoietic stem cell transplant with the majority of the hematopoietic stem cell transplant positions (83%) funded by the department of pharmacy at an academic medical center. Of the 48 responses, 22 (46%) respondents reported having collaborative practice agreements in place; 10 (21%) respondents did not currently have collaborative practice agreements, but were planning to implement them; and 16 (33%) respondents did not have collaborative practice agreements at their institution. Clinical activities performed under a collaborative practice agreement included medication selection and dosing modifications, therapeutic drug monitoring, supportive care management, and management of comorbid conditions and chronic diseases. The most commonly cited barrier to establishing collaborative practice agreements was the inability to secure reimbursement for services provided. No respondents reported a negative impact on job satisfaction. Conclusions The results of this survey provide the pharmacy community with a robust understanding of the current landscape of hematopoietic stem cell transplant pharmacy collaborative practice agreements.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%